Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence van Hunsel

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Drug Safety|December 14, 2011
Experiences with adverse drug reaction reporting by patients: an 11-country surveyFlorence van Hunsel, Linda Härmark, Shanthi Pal, et al.
Health Policy (Amsterdam, Netherlands)|June 1, 2022
Governance of nutrivigilance in the Netherlands: Reporting adverse events of non-registered productsAlie de Boer, Lisanne Geboers, Sonja van de Koppel, et al.
Drug Safety|November 9, 2022
Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine ExperienceIngrid Oosterhuis, Joep Scholl, Eugène van Puijenbroek, et al.
Pharmacoepidemiology and Drug Safety|August 1, 2014
Adverse drug reaction reports of patients and healthcare professionals-differences in reported informationLeàn Rolfes, Florence van Hunsel, Sarah Wilkes, et al.
Drug Safety|February 28, 2018
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake InhibitorsCorine Ekhart, Florence van Hunsel, Joep Scholl, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic ReviewMoa Gustafsson, Vítor Silva, Carolina Valeiro, et al.
The International Journal of Pharmacy Practice|August 14, 2013
Important information regarding reporting of adverse drug reactions: a qualitative studyLeàn Rolfes, Sarah Wilkes, Florence van Hunsel, et al.
British Journal of Clinical Pharmacology|March 10, 2018
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global databaseLeàn Rolfes, Florence van Hunsel, Ola Caster, et al.
Drug Safety|August 25, 2022
Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder AnalysisMonica van Hoof, Katherine Chinchilla, Linda Härmark, et al.
Vaccine|January 24, 2022
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomesLeàn Rolfes, Linda Härmark, Agnes Kant, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Drug Safety|December 14, 2011
Experiences with adverse drug reaction reporting by patients: an 11-country surveyFlorence van Hunsel, Linda Härmark, Shanthi Pal, et al.
Health Policy (Amsterdam, Netherlands)|June 1, 2022
Governance of nutrivigilance in the Netherlands: Reporting adverse events of non-registered productsAlie de Boer, Lisanne Geboers, Sonja van de Koppel, et al.
Drug Safety|November 9, 2022
Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine ExperienceIngrid Oosterhuis, Joep Scholl, Eugène van Puijenbroek, et al.
Pharmacoepidemiology and Drug Safety|August 1, 2014
Adverse drug reaction reports of patients and healthcare professionals-differences in reported informationLeàn Rolfes, Florence van Hunsel, Sarah Wilkes, et al.
Drug Safety|February 28, 2018
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake InhibitorsCorine Ekhart, Florence van Hunsel, Joep Scholl, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic ReviewMoa Gustafsson, Vítor Silva, Carolina Valeiro, et al.
The International Journal of Pharmacy Practice|August 14, 2013
Important information regarding reporting of adverse drug reactions: a qualitative studyLeàn Rolfes, Sarah Wilkes, Florence van Hunsel, et al.
British Journal of Clinical Pharmacology|March 10, 2018
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global databaseLeàn Rolfes, Florence van Hunsel, Ola Caster, et al.
Drug Safety|August 25, 2022
Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder AnalysisMonica van Hoof, Katherine Chinchilla, Linda Härmark, et al.
Vaccine|January 24, 2022
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomesLeàn Rolfes, Linda Härmark, Agnes Kant, et al.
Pageof 10